France approves new US COVID vaccine
US biotech company Novavax has received approval for use in France of its COVID vaccine Nuvaxovid.
Nuvaxovid – it is a biphasic vaccine based on inactivated coronavirus and is an alternative to mRNA-based vaccines.
The vaccine is not yet recommended for booster vaccination due to insufficient data on it.
Related Posts
About The Author
Elizabeth
Elizabeth Stone has been a reporter on the news desk since 2013. Before that she wrote about young adolescence and family dynamics for Styles and was the legal affairs correspondent for the Metro desk. Before joining The Quebec Telegram, Elizabeth Stone worked as a staff writer at the Village Voice and a freelancer for Newsday, The Wall Street Journal, GQ and Mirabella. To get in touch, contact me through my stone@qtelegram.com 1-800-268-7116